Seven Eight Capital’s Intellia Therapeutics NTLA Stock Holding History

Seven Eight Capital’s Portfolio NTLA Stock Details NTLA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$663K	Sell
2024 Q2	$1.26M	Buy
2024 Q1	–	Sell
2023 Q4	$1.87M	Buy
2023 Q3	$606K	Buy
2023 Q2	$473K	Buy
2023 Q1	–	Sell
2022 Q4	$470K	Buy